JRCT ID: jRCT1040230173
Registered date:20/03/2024
Prospective multicenter clinical observational study of conversion rate of hydromorphone in cancer patients
Basic Information
| Recruitment status | Recruiting |
|---|---|
| Health condition(s) or Problem(s) studied | Cancer pain |
| Date of first enrollment | 20/03/2024 |
| Target sample size | 50 |
| Countries of recruitment | |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | Conversion rate of hydromorphone |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | >= 18age old |
|---|---|
| Age maximum | Not applicable |
| Gender | |
| Include criteria | Inpatient switching from injectable to oral formulations of hydromorphone |
| Exclude criteria | Concomitant use of opioids other than hydromorphone |
Related Information
| Primary Sponsor | Nakamura Kazuyo |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Japanese Society for Pharmaceutical Palliative Care and Sciences |
| Secondary ID(s) |
Contact
| Public contact | |
| Name | Kazuyo Nakamura |
| Address | 4-27-1 Kita Ando Aoi-ku, Shizuoka City Shizuoka Japan 420-8527 |
| Telephone | +81-54-247-6111 |
| kazuyo-nakamura@i.shizuoka-pho.jp | |
| Affiliation | Shizuoka General Hospital |
| Scientific contact | |
| Name | Kazuyo Nakamura |
| Address | 4-27-1 Kita Ando Aoi-ku, Shizuoka City Shizuoka Japan 420-8527 |
| Telephone | +81-54-247-6111 |
| kazuyo-nakamura@i.shizuoka-pho.jp | |
| Affiliation | Shizuoka General Hospital |